1,673 material Form 8-K filings that 1,260 companies we cover made with the SEC in February 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Hormel Foods reported preliminary first-quarter fiscal 2026 results, expecting net sales of about $3 billion, 2% organic net sales growth and diluted EPS of $0.33 (adjusted $0.34). The company reaffirmed its fiscal 2026 organic net sales and adjusted EPS guidance and agreed to sell its whole-bird turkey business to Life-Science Innovations, which it expects to close by the end of its second fiscal quarter. The company estimates minimal impact from the sale on fiscal 2026 net sales and adjusted EPS guidance.
Preliminary Q1 fiscal 2026 net sales of about $3 billion, with 2% organic net sales growth; the company says this is its fifth consecutive quarter of year-over-year organic growth
Preliminary Q1 diluted EPS of $0.33 and adjusted diluted EPS of $0.34
Fiscal 2026 organic net sales and adjusted diluted EPS guidance reaffirmed
Definitive agreement to sell whole-bird turkey business to Life-Science Innovations; expected to close by end of fiscal Q2 2026, with financial terms not disclosed
OGE Energy reported full-year 2025 net income of $470.7 million, or $2.32 per diluted share, up from $2.19 in 2024, and gave 2026 consolidated EPS guidance of $2.38 to $2.48, with a $2.43 midpoint. Fourth-quarter 2025 earnings fell to $0.34 per diluted share from $0.50, and the Board approved a $0.425 per share second-quarter dividend.
2025 net income was $470.7 million, or $2.32 per diluted share, versus $441.5 million, or $2.19, in 2024.
Fourth-quarter 2025 net income was $69.2 million, or $0.34 per diluted share, versus $101.9 million, or $0.50, a year earlier; the filing cites a prior-year interim rate order recognized in Q4 2024.
2026 guidance: $2.38 to $2.48 per diluted share, midpoint $2.43, with targeted annual EPS growth of 5% to 7% from the midpoint.
Board approved a second-quarter dividend of $0.425 per share, payable April 24, 2026, to holders of record on April 6, 2026.
Celanese reported fourth-quarter and full-year 2025 results on February 17, 2026. Full-year net sales fell 7% to $9.5 billion, and adjusted EPS was $3.98 versus $8.18 in 2024, while the full-year U.S. GAAP diluted loss per share from continuing operations narrowed to $10.44 from $14.04. The company also guided first-quarter 2026 adjusted EPS to $0.70 to $0.85 and targets 2026 free cash flow of $650 million to $750 million.
Q4 2025 net sales were $2.2 billion, down 9% from the prior quarter and slightly below $2.358 billion in Q4 2024; Q4 adjusted EPS was $0.67 versus $1.33 a year earlier.
Full-year 2025 free cash flow was $773 million, up from $498 million in 2024, and operating cash flow was $1.1 billion.
Full-year 2025 results include Certain Items totaling $1.6 billion, primarily a goodwill and trade name impairment, which drove the U.S. GAAP loss.
First-quarter 2026 adjusted EPS guidance is $0.70 to $0.85, and the company targets 2026 free cash flow of $650 million to $750 million.
Toll Brothers reported results for the first quarter ended January 31, 2026, with net income of $210.9 million, or $2.19 per diluted share, up from $177.7 million, or $1.75, a year earlier. Home sales revenues were $1.85 billion, roughly flat, while deliveries fell to 1,899 homes from 1,991, and backlog value dropped to $6.02 billion from $6.94 billion. Management said it is maintaining full-year fiscal 2026 guidance.
Net income $210.9 million, or $2.19 per diluted share, versus $177.7 million, or $1.75, in the prior-year quarter.
Home sales revenues $1.85 billion versus $1.84 billion; delivered homes 1,899 versus 1,991.
Quarter-end backlog $6.02 billion (5,051 homes) versus $6.94 billion (6,312 homes) a year earlier.
Full-year fiscal 2026 guidance includes 10,300 to 10,700 deliveries and an adjusted home sales gross margin of 26.00%.
Hecla reported fourth quarter and full year 2025 results, with 2025 sales up 53% to $1.4 billion and net income applicable to common stockholders of $321 million, compared with $35 million in 2024. The company also lowered its 2026 Casa Berardi guidance to reflect the pending sale of that mine to Orezone Gold for up to $593 million, expected to close in the first quarter of 2026.
2025 sales were $1.4 billion, up from $929.9 million in 2024; net income was $321 million, or $0.49 per share.
Fourth quarter 2025 net income was $134.3 million on sales of $448.1 million, versus $1.6 million in the fourth quarter of 2024.
Casa Berardi sale to Orezone Gold for total consideration of up to $593 million, subject to purchase price adjustments, expected to close in Q1 2026.
Common dividend of $0.00375 per share (record March 9, 2026; payable March 24, 2026); Series B preferred dividend of $0.875 per share (record March 16, 2026; payable April 1, 2026).
EQT reported fourth-quarter and full-year 2025 results and issued 2026 guidance. Fourth-quarter net income attributable to EQT rose to $677 million, or $1.08 per diluted share, from $418 million, or $0.69, a year earlier, and full-year 2025 net income attributable to EQT reached $2.04 billion versus $231 million in 2024. The company projects about $3.5 billion of free cash flow attributable to EQT in 2026 at recent strip pricing, which shareholders will weigh against the 2026 production and capital spending plans.
Q4 2025 net income attributable to EQT was $677 million ($1.08 diluted EPS), versus $418 million ($0.69) in Q4 2024; adjusted EPS was $0.90 versus $0.67
Full-year 2025 diluted EPS was $3.31 versus $0.45 in 2024; adjusted EPS was $3.05 versus $1.60
2026 guidance: production of 2,275 to 2,375 Bcfe, maintenance capital expenditures of $2,070 to $2,210 million, and expected net debt of about $4.7 billion at year-end 2026
EQT exercised an option to buy part of ConEdison's interest in MVP Mainline and MVP Boost for a total of about $115 million payable by EQT, with closing expected in the first half of 2026
MKS Inc. reported fourth-quarter 2025 revenue of $1,033 million, up from $935 million a year earlier, with GAAP net income of $108 million and diluted EPS of $1.58. Its first-quarter 2026 guidance calls for revenue of $1,040 million plus or minus $40 million and non-GAAP EPS of $2.00 plus or minus $0.28, and the company completed a refinancing of its term loans and a €1.0 billion senior notes offering on February 4, 2026.
Q4 2025 revenue was $1,033 million, versus $935 million in Q4 2024; GAAP net income was $108 million, versus $90 million.
Q4 2025 non-GAAP net earnings per diluted share were $2.47, versus $2.15 in Q4 2024; full-year 2025 was $7.88.
Q1 2026 guidance: revenue of $1,040 million (plus or minus $40 million) and non-GAAP EPS of $2.00 (plus or minus $0.28).
On February 4, 2026, the company issued €1.0 billion of 4.25% senior notes due 2034 and refinanced its term loans, prepaying about $1.3 billion.
Rush Street Interactive reported record fourth-quarter 2025 revenue of $324.9 million, up 28%, and full-year revenue of $1,134 million, up 23%, which exceeded the high end of its prior guidance. Full-year net income rose to $74.0 million from $7.2 million, but net income attributable to Rush Street Interactive shareholders was $33.3 million after non-controlling interests, and the company initiated 2026 guidance for revenue of $1,375 million to $1,425 million and adjusted EBITDA of $210 million to $230 million.
Q4 2025 revenue was $324.9 million, up from $254.2 million; net income was $19.1 million, up from $6.5 million.
Full-year 2025 revenue was $1,134 million, up 23% from $924 million, and exceeded the high end of guidance.
Full-year 2025 diluted earnings per share attributable to Rush Street Interactive were $0.31, up from $0.03 in 2024.
2026 guidance: revenue of $1,375 million to $1,425 million and adjusted EBITDA of $210 million to $230 million.
The Andersons reported fourth quarter 2025 net income attributable to the company of $67 million, or $1.97 per diluted share, up from $45 million, or $1.31, a year earlier. Full year net income fell to $96 million, or $2.79 per diluted share, from $114 million, or $3.32, and quarterly sales declined to $2.5 billion from $3.1 billion, so shareholders see mixed results.
Q4 2025 adjusted net income was $70 million, or $2.04 per diluted share, versus $1.36 in Q4 2024
Q4 2025 sales and merchandising revenues were $2.5 billion, down from $3.1 billion a year earlier
Renewables Q4 pretax income was $54 million, up from $17 million attributable to the company in Q4 2024
Full year adjusted EBITDA was $337 million in 2025, compared with $363 million in 2024
Pitney Bowes reported fourth-quarter 2025 revenue of $478 million, down 7% from $516 million a year earlier, while adjusted EPS rose 40% to $0.45 and GAAP EPS swung to $0.17 from a loss of $0.21. The company also issued 2026 guidance with revenue of $1,760 million to $1,860 million, below 2025 revenue of $1,893 million, and adjusted EPS of $1.40 to $1.60.
Q4 2025 revenue was $478 million versus $516 million in Q4 2024, a decline of 7%; full-year revenue was $1,893 million versus $2,027 million.
Q4 2025 GAAP EPS was $0.17 versus a loss of $0.21; adjusted EPS was $0.45 versus $0.32. Full-year 2025 GAAP EPS was $0.84 and adjusted EPS was $1.35.
2026 guidance: revenue $1,760 million to $1,860 million, adjusted EBIT $410 million to $460 million, adjusted EPS $1.40 to $1.60, and free cash flow $340 million to $370 million.
In Q4 2025 the company repurchased 12.6 million shares for $127 million, and reduced principal debt by $114 million.
FirstEnergy reported 2025 GAAP earnings of $1.02 billion, or $1.77 per basic share, up from $978 million, or $1.70 per share, in 2024, on revenue of $15.1 billion. Core Earnings (non-GAAP) rose 7.6% to $2.55 per share, and the company reaffirmed its 2026 Core Earnings guidance of $2.62 to $2.82 per share, while announcing a $36 billion capital investment plan for 2026 to 2030.
2025 GAAP earnings were $1.02 billion, or $1.77 per basic share, compared with $978 million, or $1.70 per share, in 2024
Core Earnings were $2.55 per share, up 7.6% from $2.37 in 2024, at the top end of the increased and revised guidance range
2026 Core Earnings guidance of $2.62 to $2.82 per share was affirmed, and the 2026-2030 capital investment plan is $36 billion, an increase of nearly 30% over the previous five-year plan
Element Solutions reported fourth quarter and full year 2025 results on February 17, 2026. Net sales rose 8% in the quarter and 4% for the year, and adjusted EBITDA grew 5% and 2%, but GAAP net income fell 89% in the quarter and 22% for the year. The company also introduced 2026 adjusted EBITDA guidance of $650 million to $670 million, which it says includes the Micromax and EFC acquisitions.
Q4 2025 net sales were $676 million, up 8%; organic net sales rose 10%.
Q4 2025 reported net income was $6 million, down 89% from $55 million; GAAP diluted EPS was $0.03 versus $0.23.
Full year 2025 net sales were $2.55 billion and adjusted EBITDA was $548 million; reported net income was $191 million, down 22%.
2026 guidance: full year adjusted EBITDA of $650 million to $670 million and first quarter 2026 adjusted EBITDA of $140 million to $155 million.
La-Z-Boy reported fiscal third-quarter results for the period ended January 24, 2026, with sales up 4% to $542 million. GAAP diluted earnings per share fell to $0.52 from $0.68, and GAAP operating margin declined to 5.5% from 6.7%, so higher sales did not carry through to profit. The company expects fourth-quarter sales of $560 million to $580 million and an adjusted operating margin of 7.5% to 9.0%, and declared a quarterly dividend of $0.242 per share.
Quarter sales of $542 million, up 4% from the prior-year quarter; retail written sales up 11% and wholesale sales up 1%
GAAP diluted EPS of $0.52 versus $0.68 a year earlier; adjusted diluted EPS of $0.61 versus $0.68
Fourth-quarter outlook: sales of $560 million to $580 million and adjusted operating margin of 7.5% to 9.0%
Quarterly dividend of $0.242 per share declared February 17, 2026, payable March 13, 2026 to holders of record March 3, 2026
Centerspace reported full-year 2025 net income of $1.02 per diluted share, up from a net loss of $1.27 in 2024, and Core FFO of $4.93 per share, up from $4.88. For 2026 it guided to a net loss of $(0.49) to $(0.19) per diluted share and Core FFO of $4.81 to $5.05, while its strategic review of alternatives continues with no set timetable.
Q4 2025 net loss was $1.10 per diluted share, versus a $0.31 loss in Q4 2024; Q4 included a $14.5 million impairment of real estate investments.
Full-year 2025 revenue was $273.7 million, up 4.9%; same-store NOI grew 3.5%.
2026 guidance: net income (loss) per diluted share of $(0.49) to $(0.19); Core FFO per diluted share of $4.81 to $5.05, versus $4.93 in 2025.
Quarterly distribution of $0.77 per share, payable April 14, 2026, to holders of record on March 30, 2026.
JBG SMITH reported full-year 2025 results in a Form 8-K. The net loss narrowed to $139.1 million from $143.5 million, but full-year Core FFO fell to $38.9 million from $73.9 million. The filing gives no earnings guidance, and the company said it expects leverage to moderate as newly built multifamily assets lease up.
Full-year 2025 net loss was $139.1 million ($2.09 per diluted share), compared with $143.5 million ($1.65 per diluted share) in 2024.
Full-year 2025 Core FFO was $38.9 million ($0.58 per diluted share), compared with $73.9 million ($0.83 per diluted share) in 2024.
Fourth-quarter 2025 Core FFO was $9.9 million ($0.17 per diluted share), up from $11.6 million ($0.14) a year earlier, while the fourth-quarter net loss was $45.5 million ($0.78 per share).
Same Store NOI at the company's share decreased 4.2% quarter over quarter to $53.6 million in the fourth quarter.
Palo Alto Networks reported fiscal second quarter 2026 results for the quarter ended January 31, 2026, with revenue up 15% year over year to $2.6 billion and GAAP net income of $432 million, or $0.61 per diluted share, up from $267 million, or $0.38, a year earlier. The company also issued fiscal third quarter and full fiscal year 2026 guidance, including full-year revenue of $11.28 billion to $11.31 billion, which gives shareholders a forward view of expected growth.
Q2 revenue was $2.6 billion, up 15% from $2.3 billion in the year-earlier quarter.
GAAP net income was $432 million, or $0.61 per diluted share, versus $267 million, or $0.38, a year earlier.
Non-GAAP net income per diluted share was $1.03, versus $0.81 a year earlier; non-GAAP operating margin was 30.3%, versus 28.4%.
Fiscal 2026 revenue guidance is $11.28 billion to $11.31 billion, and Q3 revenue guidance is $2.941 billion to $2.945 billion.
Devon Energy reported fourth-quarter 2025 net earnings of $562 million, or $0.90 per diluted share, down from $693 million in the third quarter and $653 million a year earlier. Production averaged 851,000 Boe per day, above the top end of guidance, and the company is pursuing an all-stock merger with Coterra Energy expected to close in the second quarter of 2026, with a planned 31 percent dividend increase and a new buyback of more than $5 billion after closing.
Q4 2025 net earnings were $562 million ($0.90 per diluted share); core earnings were $510 million ($0.82 per diluted share).
Q4 2025 production averaged 851,000 Boe per day, exceeding the top end of guidance; capital investment was $883 million, 4 percent below guidance.
Merger with Coterra Energy announced Feb. 2, 2026 is expected to close in Q2 2026; quarterly dividend to rise to $0.315 per share after close.
Share repurchases were suspended with the merger announcement; Q1 2026 production is estimated to be reduced 1 percent by severe winter weather.
Rush Enterprises reported fiscal 2025 revenue of $7.4 billion and net income of $263.8 million, or $3.27 per diluted share, down from $7.8 billion and $304.2 million, or $3.72 per diluted share, in 2024. Fourth-quarter net income also declined to $64.3 million, or $0.81 per diluted share, from $74.8 million, or $0.91, and management said it expects industry conditions to remain challenging in the first quarter of 2026.
FY2025 revenue was $7.4 billion versus $7.8 billion in 2024; net income was $263.8 million versus $304.2 million.
Q4 2025 revenue was $1.8 billion versus $2.0 billion in Q4 2024; Q4 net income was $64.3 million, or $0.81 per diluted share, versus $0.91.
The Board declared a quarterly cash dividend of $0.19 per share, payable March 18, 2026, to holders of record as of March 3, 2026.
Management expects industry conditions to remain challenging in the first quarter of 2026 and is cautiously optimistic about the rest of the year.
Glaukos reported record fourth-quarter 2025 net sales of $143.1 million, up 36% from a year earlier, and full-year net sales of $507.4 million, up 32%. A one-time, non-cash impairment charge of $112.9 million tied to the Photrexa to Epioxa transition pushed the fourth-quarter GAAP net loss to $133.7 million, or $2.32 per diluted share, and the company reaffirmed its 2026 net sales guidance of $600 million to $620 million.
Q4 2025 net sales were $143.1 million, up 36% reported and 34% in constant currency, versus $105.5 million in Q4 2024.
Q4 2025 GAAP net loss was $133.7 million, or ($2.32) per diluted share, versus a net loss of $33.6 million, or ($0.60), in Q4 2024.
Non-GAAP net loss for Q4 2025 was $16.4 million, or ($0.28) per diluted share.
The company reaffirmed 2026 net sales guidance of $600 million to $620 million and ended 2025 with about $282.6 million in cash, short-term investments and restricted cash and no debt.
Caesars Entertainment reported fourth-quarter 2025 GAAP net revenues of $2.9 billion, up from $2.8 billion, but a GAAP net loss of $250 million, compared with net income of $11 million a year earlier. The prior-year period included gains on asset sales of over $350 million. Same-store Adjusted EBITDA rose to $901 million, with Caesars Digital setting a quarterly record, while full-year net loss widened to $502 million and full-year same-store Adjusted EBITDA fell to $3.6 billion.
Q4 GAAP net revenues $2.9 billion vs $2.8 billion; Q4 same-store Adjusted EBITDA $901 million vs $882 million
Q4 net loss attributable to Caesars $250 million vs net income of $11 million, driven mainly by prior-year asset sale gains of over $350 million
Full year net loss $502 million vs $278 million; full year same-store Adjusted EBITDA $3.6 billion vs $3.7 billion
Caesars Digital Q4 Adjusted EBITDA $85 million vs $20 million; company expects lower capex and cash interest in 2026
Mercury General reported fourth-quarter 2025 net income of $202.5 million, or $3.66 per diluted share, up from $101.1 million, or $1.82, a year earlier, and full-year net income of $541.1 million, or $9.77 per share, up 15.6%. The company also declared a quarterly dividend of $0.3175 per share, and it says Palisades and Eaton wildfire net losses of about $380 million for 2025 remain a significant factor in its results.
Q4 2025 net income was $202.5 million ($3.66 per diluted share) versus $101.1 million ($1.82) in Q4 2024.
Q4 2025 combined ratio was 88.6% versus 91.4%; net premiums earned rose 6.9% to $1.45 billion.
Full-year 2025 net income was $541.1 million, up 15.6%, while catastrophe losses net of reinsurance were $508 million versus $277 million.
Quarterly dividend of $0.3175 per share is payable March 26, 2026 to shareholders of record on March 12, 2026.
Rogers reported fourth-quarter 2025 net sales of $201.5 million, up 4.8% from a year earlier, and adjusted earnings of $0.89 per diluted share versus $0.46. For the full year, the company swung to a net loss of $61.8 million, or $(3.40) per diluted share, after $97.1 million of restructuring and impairment charges, compared with net income of $26.1 million in 2024. The company also gave first-quarter 2026 guidance of $193 million to $208 million in net sales and $0.45 to $0.85 in adjusted earnings per diluted share.
Q4 2025 net sales were $201.5 million, up from $192.2 million, and GAAP earnings were $0.26 per diluted share versus a loss of $(0.03) a year earlier
Full-year 2025 net sales were $810.8 million, down from $830.1 million, and net loss was $(61.8) million versus net income of $26.1 million in 2024
Restructuring and impairment charges were $97.1 million for 2025 compared with $24.1 million in 2024
Q1 2026 guidance: net sales $193 million to $208 million, adjusted EBITDA $27 million to $35 million, adjusted EPS $0.45 to $0.85
Goosehead Insurance reported fourth-quarter 2025 revenue up 12% to $105.3 million, while net income fell to $20.8 million from $23.8 million a year earlier. The company also gave 2026 guidance of 10% to 19% organic total revenue growth, expanded its share repurchase authorization by $180.0 million, and added Louis Goldberg to its board, effective February 18, 2026. For shareholders, revenue growth was offset by lower profit, and the buyback expansion and guidance will shape expectations for 2026.
Q4 2025 total revenues were $105.3 million, up 12%; Q4 net income was $20.8 million versus $23.8 million, and diluted EPS was $0.48 versus $0.57.
Full-year 2025 net income was $44.5 million versus $49.1 million in 2024; Adjusted EBITDA rose 14% to $113.6 million.
2026 guidance: total revenues expected to grow organically 10% to 19%, and total written premiums 12% to 20%.
Share repurchase authorization increased by $180.0 million and extended through May 1, 2027; $81.7 million of shares were repurchased in 2025.
HealthEquity said its HSA Assets reached $36.5 billion as of January 31, 2026, up 14% from a year earlier, and its HSA count rose 7% to 10.6 million. The company reaffirmed its fiscal 2026 and 2027 outlook and said fiscal 2026 results are expected to be near the top end of previously provided ranges, which signals strong sales for shareholders while full fiscal 2027 guidance is deferred to March.
Fourth-quarter new HSAs from sales rose 17% year over year, and the company reported more than one million new HSA accounts from sales for fiscal 2026.
Total HSA Assets were $36.5 billion, up 14% from $32.1 billion, with HSA investments up 26% to $18.5 billion.
Total Accounts reached 17.8 million, up 4%, and the company expects to provide full fiscal 2027 guidance when it reports year-end results in March.
The fourth-quarter and fiscal 2026 results conference call is scheduled for March 17, 2026, at 4:30 p.m. Eastern Time.
Republic Services reported fourth-quarter 2025 diluted EPS of $1.76, up from $1.63 a year earlier, on revenue of $4,136 million, up 2.2%. For full-year 2025, diluted EPS rose to $6.85 from $6.49, and the company expects 2026 adjusted diluted EPS of $7.20 to $7.28 on revenue of $17.050 billion to $17.150 billion.
Q4 2025 net income was $545 million, or $1.76 per diluted share, versus $512 million, or $1.63, in Q4 2024.
Q4 2025 adjusted EPS was $1.76, up 11.4% from $1.58 in the prior-year quarter.
Full-year 2025 adjusted EPS was $7.02, up 8.7% from $6.46; cash returned to shareholders was $1.6 billion.
2026 guidance: revenue of $17.050 billion to $17.150 billion and adjusted EBITDA of $5.475 billion to $5.525 billion.
Axcelis Technologies reported fourth-quarter 2025 revenue of $238.3 million, down from $252.4 million a year earlier, and diluted EPS of $1.10 versus $1.54. For the full year, revenue was $839.0 million compared with $1.02 billion in 2024, and diluted EPS was $3.80 versus $6.15. The company expects first-quarter 2026 revenue of approximately $195 million and says it continues working toward closing its pending merger with Veeco Instruments.
Q4 2025 net income was $34.3 million, versus $50.0 million in Q4 2024; GAAP diluted EPS was $1.10, versus $1.54.
Full-year 2025 revenue was $839.0 million, versus $1.02 billion in 2024; full-year GAAP diluted EPS was $3.80, versus $6.15.
Q1 2026 outlook: revenue of approximately $195 million, GAAP diluted EPS of approximately $0.38, and non-GAAP EPS of approximately $0.71.
Q4 2025 included $7.5 million of transaction and integration costs tied to the Veeco merger agreement announced October 1, 2025.
Halozyme reported fourth-quarter 2025 total revenue of $451.8 million, up 52% from a year earlier, but a net loss of $141.6 million, which included $284.9 million of acquired in-process R&D expense tied to the Surf Bio acquisition. For full-year 2025, total revenue rose 38% to $1.4 billion, and the company reiterated its 2026 guidance for total revenue of $1.710 billion to $1.810 billion and non-GAAP diluted EPS of $7.75 to $8.25.
Q4 2025 total revenue was $451.8 million versus $298.0 million in Q4 2024; royalties were $258.0 million, up 51%.
Q4 2025 net loss was $141.6 million versus net income of $137.0 million a year earlier; GAAP diluted loss was $1.20 per share.
Full-year 2025 total revenue was $1,396.6 million, up 38%, with royalty revenue of $867.8 million, up 52%.
2026 guidance reiterated: total revenue of $1.710 billion to $1.810 billion and non-GAAP diluted EPS of $7.75 to $8.25, last updated January 28, 2026.
Cadence reported fourth-quarter 2025 revenue of $1.440 billion, up from $1.356 billion a year earlier, and fiscal 2025 revenue of $5.297 billion, up from $4.641 billion. Fiscal 2025 GAAP diluted earnings per share rose to $4.06 from $3.85, while GAAP operating margin fell to 28.2% from 29.1%. For 2026, Cadence expects GAAP diluted EPS of $4.95 to $5.05 and non-GAAP diluted EPS of $8.05 to $8.15, excluding its pending Hexagon design and engineering acquisition.
Q4 2025 revenue was $1.440 billion versus $1.356 billion in Q4 2024; GAAP diluted EPS was $1.42 versus $1.24.
Fiscal 2025 non-GAAP diluted EPS was $7.14 versus $5.97 in 2024; GAAP operating margin was 28.2% versus 29.1%.
2026 outlook: revenue of $5.9 billion to $6.0 billion and non-GAAP diluted EPS of $8.05 to $8.15, excluding the pending Hexagon D&E acquisition.
Q1 2026 outlook: revenue of $1.420 billion to $1.460 billion, with approximately $200 million expected for share repurchases in the quarter.
RB Global reported fourth-quarter 2025 results with total revenue up 5% to $1.2 billion, while net income and diluted EPS fell 8% and 9%, respectively. The company also gave 2026 guidance for adjusted EBITDA of $1,470 million to $1,530 million and disclosed a $59.6 million arbitration award to its former CEO, which is reflected in its 2025 financial statements.
Q4 2025 total revenue rose 5% year over year to $1.2 billion; net income fell 8% to $109.4 million.
Diluted EPS fell 9% to $0.53; diluted adjusted EPS rose 17% to $1.11.
2026 outlook: adjusted EBITDA of $1,470 million to $1,530 million, versus $1,399.7 million in 2025.
On February 16, 2026, an arbitration panel awarded the former CEO $59.6 million; a quarterly dividend of $0.31 per share is payable March 2, 2026.
Expand Energy reported fourth-quarter and full-year 2025 results and issued its 2026 outlook. Net income turned from losses in 2024 to profits in 2025, with the company citing higher production and lower debt, and it plans to prioritize debt reduction of at least $1 billion in 2026 while continuing the base dividend and opportunistic share repurchases.
Q4 2025 net income of $553 million, or $2.30 per diluted share, compared with a net loss of $399 million, or $1.72 per share, in Q4 2024
Full-year 2025 net income of $1,819 million, or $7.57 per diluted share, compared with a net loss of $714 million in 2024
2026 outlook: approximately $2.85 billion of capital and about 7.5 Bcfe/d of daily production, with debt reduction of at least $1 billion
Quarterly base dividend of $0.575 per share, payable March 26, 2026, to holders of record on March 5, 2026
Itron reported fourth-quarter 2025 revenue of $572 million, down 7% from a year earlier, while GAAP diluted earnings per share rose to $2.21 from $1.26, helped by a tax benefit. For 2026, the company forecast non-GAAP diluted EPS of $5.75 to $6.25, compared with $7.13 for full-year 2025, and revenue of $2.35 billion to $2.45 billion.
Q4 2025 revenue was $572 million, down 7%, driven by portfolio optimization and the timing of project deployments.
Q4 GAAP diluted EPS was $2.21 versus $1.26; non-GAAP diluted EPS was $2.46 versus $1.35.
Full-year 2025 revenue was $2.4 billion, down 3%; full-year non-GAAP diluted EPS was $7.13.
2026 outlook: Q1 revenue $565 million to $575 million; full-year revenue $2.35 billion to $2.45 billion and non-GAAP diluted EPS $5.75 to $6.25.
LGI Homes reported fourth-quarter 2025 home sales revenues of $474.0 million, down from $557.4 million a year earlier, and net income of $17.3 million, or $0.75 diluted EPS, versus $50.9 million, or $2.15, in the prior-year quarter. For full-year 2025, net income was $72.6 million, or $3.12 diluted EPS, compared with $196.1 million, or $8.30, in 2024. The company also issued 2026 guidance calling for 4,600 to 5,400 home closings and a gross margin of 18.0% to 20.0%, compared with 20.7% in 2025.
Q4 2025 home sales revenues were $474.0 million, versus $557.4 million in Q4 2024
Q4 2025 diluted EPS was $0.75, versus $2.15; full-year 2025 diluted EPS was $3.12, versus $8.30
2026 guidance: 4,600 to 5,400 home closings and average sales price of $355,000 to $365,000
Year-end 2025 backlog was 1,394 homes valued at $501.3 million, including a wholesale contract to deliver 480 homes during 2026
Kite Realty Group reported fourth-quarter 2025 net income attributable to common shareholders of $180.8 million, or $0.84 per diluted share, up from $21.8 million a year earlier, mainly due to a $183.1 million gain on property sales. Core FFO fell to $112.9 million, or $0.51 per diluted share, from $0.52 a year earlier, and total revenue declined, while the company issued initial 2026 guidance of $2.06 to $2.12 per diluted share for Core FFO.
Q4 2025 net income attributable to common shareholders was $180.8 million, or $0.84 per diluted share, versus $21.8 million, or $0.10, in Q4 2024.
Q4 2025 Core FFO of the Operating Partnership was $112.9 million, or $0.51 per diluted share, versus $0.52 in Q4 2024; total revenue was $204.9 million versus $212.2 million.
2026 guidance: Core FFO of $2.06 to $2.12 per diluted share and net income of $0.36 to $0.42 per diluted share.
Board declared a first quarter 2026 dividend of $0.29 per common share, a 7.4% year-over-year increase, payable on or about April 16, 2026.
Franklin Electric reported fourth quarter 2025 net sales of $506.9 million, up 4%, and diluted EPS of $0.87, up from $0.72. For full year 2025, GAAP diluted EPS fell to $3.22 from $3.86 after a $54.9 million pre-tax pension settlement charge from terminating its US Pension Plan, while adjusted diluted EPS rose 6% to $4.14. The company also guided 2026 sales of $2.17 billion to $2.24 billion and adjusted diluted EPS of $4.40 to $4.60.
Q4 2025 operating income was $51.6 million, up 20% from $43.0 million, with operating margin of 10.2%.
Full year 2025 net sales were $2.1 billion, up 5%, and operating income was $269.0 million, up 10%.
The US Pension Plan termination cut full year 2025 GAAP diluted EPS by an estimated $0.91 per share net of tax, according to the company.
2026 guidance: sales of $2.17 billion to $2.24 billion and adjusted diluted EPS of $4.40 to $4.60.
Watsco reported full-year 2025 revenue of $7.24 billion, down 5%, and diluted earnings per share of $12.25 versus $13.30 in 2024. Fourth-quarter revenue fell 10% to $1.58 billion and quarterly EPS was $1.68 versus $2.37. The board also approved a 10% increase in the annual dividend to $13.20 per share, payable starting with the April 2026 payment.
Full-year 2025 revenue $7.24 billion, down 5%; operating income $720 million, down 8%
Full-year gross profit margin rose to a record 28.0%, up 120 basis points
Fourth-quarter EPS $1.68 versus $2.37 a year earlier; operating cash flow for the quarter was a record $400 million
Annual dividend raised 10% to $13.20 per share, reflected in the April 2026 payment
Valmont reported fourth-quarter 2025 diluted GAAP EPS of $9.05, up from $3.84, and adjusted EPS of $4.92, up 28.1%, on net sales that rose 0.1% to $1.04 billion. The company also introduced a 2026 outlook of $4.2 to $4.4 billion in net sales and $20.50 to $23.50 in diluted EPS, which compares with full-year 2025 adjusted EPS of $19.09.
Q4 2025 diluted GAAP EPS was $9.05 versus $3.84; adjusted EPS was $4.92, up 28.1%. GAAP EPS included a $3.98 benefit from a lower effective tax rate.
Q4 Agriculture sales fell 19.9% to $222.7 million, and the segment posted an operating loss of $3.4 million including $27.5 million of Brazil legal and credit loss expense.
Full-year 2025 diluted GAAP EPS was $16.79, down 2.3%; adjusted EPS rose 11.1% to $19.09. Full-year net sales were $4.10 billion, up 0.7%.
2026 outlook: net sales of $4.2 to $4.4 billion, diluted EPS of $20.50 to $23.50, and capital expenditures of $170 to $200 million.
Krystal Biotech reported fourth-quarter and full-year 2025 results, with product revenue from VYJUVEK rising from the prior-year periods. Net income for the quarter was $51.4 million, or $1.70 per diluted share, compared with $45.5 million, or $1.52 per diluted share, a year earlier. The company also issued fiscal 2026 non-GAAP R&D and SG&A expense guidance of $175.0 million to $195.0 million.
Q4 2025 product revenue, net, was $107.1 million, up from $91.1 million in Q4 2024.
Full-year 2025 product revenue, net, was $389.1 million, up from $290.5 million in 2024.
Full-year 2025 net income was $204.8 million, or $6.84 per diluted share, versus $89.2 million, or $3.00 per diluted share, in 2024.
FY 2026 non-GAAP R&D and SG&A expense guidance is $175.0 million to $195.0 million, excluding stock-based compensation.
NeoGenomics reported fourth-quarter and full-year 2025 results on February 17, 2026, with full-year revenue up 10% to $727 million and a full-year net loss of $108 million, up 37% from 2024. The company also issued 2026 guidance calling for revenue of $793 million to $801 million and a net loss of $50 million to $63 million, which matters to shareholders because it sets the company's first public outlook for 2026.
Q4 2025 revenue rose 11% to $190 million; Q4 net loss narrowed 36% to $10 million
Full-year 2025 net loss was $108 million, up from $79 million in 2024, including $27.8 million in impairment charges
2026 guidance: revenue of $793 million to $801 million, net loss of $50 million to $63 million, adjusted EBITDA of $55 million to $57 million
The filing says the RaDaR ST patent litigation was successfully resolved
Vulcan Materials reported fourth-quarter 2025 net earnings attributable to Vulcan of $252 million, down from $294 million a year earlier, while revenue rose to $1.91 billion from $1.85 billion. For full-year 2025, revenue, net earnings and diluted EPS from continuing operations all increased, and the company gave 2026 guidance calling for Adjusted EBITDA of $2.4 billion to $2.6 billion.
Q4 2025 diluted EPS attributable to Vulcan was $1.91, versus $2.23 in Q4 2024; adjusted diluted EPS was $1.70, versus $2.17.
Full-year 2025 total revenues were $7.94 billion, versus $7.42 billion, and diluted EPS from continuing operations was $8.15, versus $6.91.
2026 outlook: net earnings attributable to Vulcan of $1.1 billion to $1.3 billion and Adjusted EBITDA of $2.4 billion to $2.6 billion.
Cash from operating activities was $1.8 billion in 2025, up 29 percent; the company returned $698 million to shareholders through buybacks and dividends.
Knife River reported record fourth-quarter 2025 revenue of $755.1 million, up 15%, and net income of $32.0 million, up 38%. For the full year, revenue rose 9% to $3.15 billion, but net income fell 22% to $157.1 million, and the company issued 2026 guidance of $3.3 billion to $3.5 billion in revenue and $520 million to $560 million in adjusted EBITDA.
Q4 2025 diluted EPS was $0.56, versus $0.41 a year earlier; full-year diluted EPS was $2.76, versus $3.55 in 2024.
Full-year 2025 adjusted EBITDA rose 7% to $496.5 million, while the adjusted EBITDA margin fell to 15.8% from 16.0%.
2026 guidance: revenue of $3.3 billion to $3.5 billion and adjusted EBITDA of $520 million to $560 million, based on normal weather and conditions and excluding potential acquisitions.
The company completed five acquisitions in 2025 and reported year-end backlog of $1.03 billion, versus $745.6 million a year earlier.
Fluor reported fourth-quarter and full-year 2025 results. The fourth-quarter net loss attributable to Fluor was $1.6 billion, or $(9.87) per diluted share, compared with net earnings of $1.9 billion a year earlier, reflecting a net $2 billion reduction in the valuation of its NuScale investment. For the full year, revenue was $15.5 billion, down from $16.3 billion, and the company reported a net loss of $51 million, or $(0.31) per share, including a $643 million adverse Santos ruling.
Q4 2025 net loss attributable to Fluor of $1.6 billion, or $(9.87) per diluted share, versus net earnings of $1.9 billion, or $10.57 per share, in Q4 2024.
Full-year 2025 adjusted EPS of $2.19, down from $2.32 in 2024; operating cash flow was $(387) million versus $828 million.
Fluor set 2026 adjusted EBITDA guidance of $525 million to $585 million, compared with $504 million in 2025.
Received $1.35 billion in Q1 2026 from NuScale share sales; plans $1.4 billion in share repurchases for 2026.
DFIN reported fourth-quarter 2025 net sales of $172.5 million, up 10.4%, and Adjusted EBITDA of $45.8 million, up 44.5%, while GAAP net earnings of $6.2 million were roughly flat against $6.3 million a year earlier. For the full year, net sales fell 1.9% to $767.0 million and net earnings fell 64.9% to $32.4 million, reflecting an $82.8 million pension plan settlement charge. The company guided first-quarter 2026 total net sales to $200 million to $210 million.
Q4 2025 net sales were $172.5 million, up 10.4% from $156.3 million in Q4 2024, led by software solutions growth of 11.4%.
Q4 2025 GAAP net earnings were $6.2 million, or $0.23 per diluted share, versus $6.3 million, or $0.21, in Q4 2024.
Full-year 2025 net earnings were $32.4 million versus $92.4 million in 2024, including an $82.8 million pension plan settlement charge.
First-quarter 2026 guidance: total net sales of $200 million to $210 million and Adjusted EBITDA margin of 33% to 35%.
DTE Energy reported 2025 net income of nearly $1.5 billion, or $7.03 per diluted share, versus $6.77 in 2024, and operating earnings of $7.36 per share versus $6.83. The company confirmed its 2026 operating EPS guidance of $7.59 to $7.73 and said a $6.5 billion increase to its five-year capital investment plan is driven by an Oracle data center agreement and utility modernization needs.
2025 operating EPS of $7.36 was above the high end of the company's guidance, driven by its non-utility operations.
2026 operating EPS guidance of $7.59 to $7.73 was confirmed, and the company expects to reach the high end of the range due to RNG tax credits.
The five-year capital plan rose by $6.5 billion, and the company expects to reach final terms on additional data center customers in the first quarter of 2026.
Labcorp reported fourth-quarter 2025 revenue of $3.52 billion, up from $3.33 billion, and full-year revenue of $13.95 billion, up from $13.01 billion. Full-year diluted EPS rose to $10.46 from $8.84, and the company provided 2026 guidance calling for adjusted EPS of $17.55 to $18.25, compared with $16.44 in 2025. Fourth-quarter restructuring and other charges of $110.8 million, up from $11.4 million a year earlier, were a notable offsetting item.
Q4 2025 diluted EPS was $1.98 vs $1.70 a year earlier; Q4 adjusted EPS was $4.07 vs $3.45
2026 guidance: revenue of $14.61 billion to $14.79 billion and free cash flow of $1.24 billion to $1.36 billion
Q4 2025 free cash flow was $490.3 million vs $665.1 million, which the company attributed to working capital timing
Quarterly dividend of $0.72 per share is payable March 12, 2026, to holders of record on February 27, 2026
Medtronic reported fiscal third-quarter 2026 revenue of $9.017 billion, up 8.7% as reported and 6.0% organic, but GAAP diluted EPS fell to $0.89 from $1.01 a year earlier and non-GAAP diluted EPS fell to $1.36 from $1.39. The company reiterated its FY26 organic revenue growth of about 5.5% and non-GAAP diluted EPS guidance of $5.62 to $5.66, so shareholders see sales growth alongside lower profit per share in the quarter.
Q3 revenue of $9.017 billion, up 8.7% as reported and 6.0% organic, 50 basis points ahead of Q3 guidance
GAAP diluted EPS of $0.89 vs. $1.01 a year earlier; non-GAAP diluted EPS of $1.36 vs. $1.39
Cardiovascular Portfolio revenue of $3.457 billion, up 13.8%; Cardiac Ablation Solutions revenue up 80%
FY26 guidance reiterated: organic revenue growth of about 5.5% and non-GAAP diluted EPS of $5.62 to $5.66, including a potential tariff impact of about $185 million
Waystar reported fourth-quarter and full-year 2025 results and gave full-year 2026 guidance. Revenue grew 24% in the quarter and 17% for the year, and full-year net income was $112.1 million, compared with a loss of $19.1 million in 2024. Quarterly diluted EPS of $0.10 was slightly below the $0.11 reported a year earlier.
Q4 2025 revenue was $303.5 million, up 24% year-over-year; Q4 net income was $20.0 million, or $0.10 diluted EPS
FY 2025 revenue was $1,099.3 million, up 17%; FY net income was $112.1 million versus a $19.1 million loss in 2024
2026 guidance: revenue of $1.274 billion to $1.294 billion and adjusted EBITDA of $530 million to $540 million
2026 non-GAAP diluted EPS guidance is $1.59 to $1.68
Somnigroup reported fourth-quarter 2025 net sales of $1.87 billion, up 54.7%, with diluted EPS up 65.0% to $0.66, largely due to the inclusion of Mattress Firm, which it acquired on February 5, 2025. The company guided 2026 adjusted EPS to $3.00 to $3.40 and raised its quarterly dividend 13% to $0.17 per share, payable March 19, 2026, while full-year 2025 GAAP EPS fell 14.8% to $1.84.
Q4 2025 net sales rose 54.7% to $1,868.4 million; diluted EPS rose 65.0% to $0.66; adjusted EPS rose 20.0% to $0.72.
Full-year 2025 diluted EPS was $1.84, down 14.8% from $2.16; full-year adjusted EPS was $2.70, up 5.9%.
2026 adjusted EPS guidance is $3.00 to $3.40, about a 19% increase at the midpoint over 2025 adjusted EPS.
Quarterly dividend increased to $0.17 per share, payable March 19, 2026, to holders of record on March 5, 2026.
CNH Industrial reported fourth-quarter 2025 consolidated revenues up 6% to $5.16 billion, but net income fell 49% to $89 million and diluted EPS fell to $0.07 from $0.14. For full-year 2025, revenues declined 9% to $18.10 billion and net income fell to $505 million from $1,259 million. The company expects global industry retail demand for agricultural equipment to be about 5% lower in 2026 and forecasts 2026 adjusted diluted EPS of $0.35 to $0.45.
Q4 2025 net income was $89 million, versus $176 million in Q4 2024; Q4 included $123 million in non-cash impairment charges tied to the 2021 Raven acquisition and $62 million tied to Monarch Tractor and other minority holdings.
Full-year 2025 consolidated revenues were $18.10 billion, down 9%; full-year diluted EPS was $0.41, versus $0.99 in 2024; adjusted diluted EPS was $0.55, versus $1.05.
2026 outlook: Agriculture net sales down 5% to flat year-over-year; Industrial free cash flow of $150 million to $350 million; adjusted diluted EPS of $0.35 to $0.45.
Full-year 2025 net cash provided by operating activities was $2,538 million, and Industrial free cash flow was $513 million.
Allegion reported fourth-quarter 2025 net revenues of $1,033.2 million, up 9.3%, and diluted EPS of $1.70, up 3.0%, with adjusted EPS of $1.94, up 4.3%. The company also gave 2026 guidance calling for reported revenue growth of 5% to 7% and adjusted EPS of $8.70 to $8.90, compared with 2025 adjusted EPS of $8.14.
Q4 2025 revenue of $1,033.2 million, up 9.3% reported and 3.3% organic; Americas organic revenue up 4.8%
Q4 2025 diluted EPS of $1.70 vs. $1.65; adjusted EPS of $1.94 vs. $1.86
Full-year 2025 adjusted EPS of $8.14, up 8.1%; reported EPS of $7.44, up 9.1%
2026 outlook: reported revenue growth 5% to 7%, reported EPS $8.00 to $8.20, adjusted EPS $8.70 to $8.90
Louisiana-Pacific reported fourth-quarter 2025 net sales of $567 million, down $114 million, and a net loss of $8 million, compared with net income of $63 million a year earlier. For full year 2025, net income fell $275 million to $146 million, or $2.08 per diluted share, and the company forecast full year 2026 consolidated Adjusted EBITDA of $430 million.
Q4 2025 net loss of $8 million, or $(0.11) per diluted share, versus net income of $63 million in Q4 2024; net sales fell $114 million to $567 million.
Full year 2025 net income was $146 million ($2.08 per diluted share), down $275 million; Adjusted EBITDA was $436 million, down $252 million.
2026 outlook: first quarter consolidated Adjusted EBITDA of $50 million and full year of $430 million; full year Siding net sales of about $1.7 billion.
Quarterly dividend set at $0.30 per share for Q1 2026, up from $0.28; about $1 billion total liquidity as of December 31, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.